Followers | 44 |
Posts | 3229 |
Boards Moderated | 2 |
Alias Born | 01/18/2016 |
Friday, November 17, 2023 7:57:09 AM
All my postings are verified and approved by my dog.
Recent COYA News
- Coya Therapeutics to Participate in Fireside Chat at the Chardan 8th Annual Genetic Medicines Conference • Business Wire • 09/24/2024 12:15:00 PM
- Coya Therapeutics Announces Subcutaneously Administered COYA 302 Elicits Direct Anti-Inflammatory Effect in Brain in a Preclinical Inflammatory Mouse Model of Parkinson’s Disease • Business Wire • 09/16/2024 12:15:00 PM
- Coya Therapeutics to Present at Upcoming Healthcare Conferences • Business Wire • 09/03/2024 12:15:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 07:56:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 01:10:00 PM
- Coya Therapeutics Promotes Arun Swaminathan Ph.D. to Chief Executive Officer Effective November 1st, 2024 • Business Wire • 08/19/2024 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 12:13:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 12:04:26 PM
- Coya Therapeutics Provides a Corporate Update and Reports Unaudited Second Quarter 2024 Financial Results • Business Wire • 08/12/2024 12:00:00 PM
- Coya Therapeutics Announces that Results from a Double-Blind Placebo-Controlled Study in Alzheimer’s Disease will be presented on October 29, 2024 at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) in Madrid • Business Wire • 08/02/2024 12:15:00 PM
- Coya Therapeutics Expands Pipeline and Intellectual Property Portfolio with Filing of New U.S. Patents for COYA 301 in Combination with Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists • Business Wire • 07/31/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/15/2024 10:10:01 AM
- Coya Therapeutics Expands Sponsored Research Collaboration with Houston Methodist Research Institute Along with Funding from the Johnson Center for Cellular Therapeutics to Advance Regulatory T Cell Exosome Platform into the Clinic • Business Wire • 06/20/2024 12:15:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/14/2024 09:01:07 PM
- Coya Therapeutics Announces Publication of ALS Study in Peer-Reviewed Journal Frontiers in Neurology • Business Wire • 06/11/2024 12:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 12:00:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2024 12:00:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 12:00:32 PM
- Coya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in Neurology • Business Wire • 06/03/2024 12:15:00 PM
- Coya Therapeutics Announces Inclusion in the MSCI USA Micro Cap Index • Business Wire • 05/28/2024 12:15:00 PM
- Coya Therapeutics Announces the Completion of a Controlled Phase 2 Study of Low Dose Interleukin-2 (LD IL-2) in Patients with Alzheimer’s Disease • Business Wire • 05/22/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 09:00:35 PM
- Coya Therapeutics Announces $5 Million Strategic Investment by the Alzheimer’s Drug Discovery Foundation (ADDF) • Business Wire • 05/20/2024 12:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:26:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:20:17 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM